Under construction – not a live service
Sign in
Not yet taking people in TürkiyeNo phase

Sedentary Status and Multidimensional Outcomes in Fibromyalgia

Key facts

Where
Konak, TürkiyeSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07358702, who can take part

Where in Türkiye

  • Betül TAŞPINARKonak, TürkiyeContact: Ferruh Taşpınar, Prof.Dr.No longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Izmir Democracy University
Trial code
NCT07358702
Record updated
6 February 2026
Original description
Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and functional limitations. Pain, fatigue, and fear of movement often lead individuals with FMS to adopt sedentary behaviors, which may further exacerbate symptoms and reduce physical capacity. Factors such as impaired body awareness, reduced respiratory muscle strength, kinesiophobia, central sensitization, poor functional status, and sleep disturbances play an important role in disease severity and quality of life in individuals with FMS.Read full original descriptionShow less

Comparison of Body Awareness, Respiratory Muscle Strength, Kinesiophobia, Central Sensitization, Functional Status and Sleep Quality in Sedentary and Non-Sedentary Fibromyalgia Individuals

Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and functional limitations. Pain, fatigue, and fear of movement often lead individuals with FMS to adopt sedentary behaviors, which may further exacerbate symptoms and reduce physical capacity. Factors such as impaired body awareness, reduced respiratory muscle strength, kinesiophobia, central sensitization, poor functional status, and sleep disturbances play an important role in disease severity and quality of life in individuals with FMS.

Although physical inactivity is common in fibromyalgia, limited evidence exists regarding the differences in these multidimensional clinical parameters between sedentary and non-sedentary individuals with FMS. Therefore, the aim of this study is to compare body awareness, respiratory muscle strength, kinesiophobia, central sensitization, functional status, and sleep quality between sedentary and non-sedentary individuals diagnosed with fibromyalgia syndrome. The findings of this study may contribute to a better understanding of the impact of sedentary behavior on clinical outcomes in fibromyalgia and help guide more comprehensive and individualized rehabilitation approaches.

Inclusion: Physical activity level below 600 MET-min/week according to the International Physical Activity Questionnaire (IPAQ); Diagnosis of fibromyalgia according to the 2016 ACR criteria; Age between 18 and 65 years; Ability to understand and respond to study assessments.

Exclusion: Conditions posing risk during assessments, including unstable angina, decompensated heart failure, or myocardial infarction within the past month; Uncontrolled diabetes, hypertension >180/110 mmHg, and/or severe neuropathy; Diagnosed severe cognitive impairment; Conditions posing risk during assessments, including unstable angina, decompensated heart failure, or myocardial infarction within the past month; Uncontrolled diabetes, hypertension >180/110 mmHg, and/or severe neuropathy; Diagnosed severe cognitive impairment; Age between 18 and 65 years; Pregnancy or suspected pregnancy Inclusion Criteria - Non-Sedentary Fibromyalgia Participants; Physical activity level above 600 MET-min/week according to the IPAQ; Diagnosis of fibromyalgia according to the 2016 ACR criteria; Ability to understand and respond to study assessments; Pregnancy or suspected pregnancy.

ClinicalTrials.gov NCT07358702